DC-CIK immune cell therapy
/ Bohui Biotech, National Taiwan University Hospital
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
November 21, 2022
Valuation of the Safety and Efficacy of Combination of Cryoablation and Dendric Cell/Cytokine-induced Killers Cells Treatment for Advanced Liver Cancers
(clinicaltrials.gov)
- P1/2 | N=15 | Not yet recruiting | Sponsor: National Taiwan University Hospital
New P1/2 trial • Gastrointestinal Cancer • Hepatocellular Cancer • Hepatology • Liver Cancer • Oncology • Solid Tumor
1 to 1
Of
1
Go to page
1